PAVM

PAVmed Inc

1.84

Nov 03 • 4:06 AM ET -0.07 (-3.66%)

Healthcare Medical Devices USA Nano NASD

Today, 8:20 AMPAVmed's Lucid Diagnostics publishes peer-reviewed 11,991-patient real-world study of EsoGuard/EsoCheck esophageal precancer testing platform

Peers: LUCD VNRX CV PRPO MDXH SERA BIAF AIDX IMDX BDSX

| Held by: VXF IWC

Scroll to Statements

Index	-
Market Cap	14.71M
Enterprise Value	16.11M
Income	-20.63M
Sales	0.11M
Book/sh	4.98
Cash/sh	0.47
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	41
IPO	Apr 28, 2016

P/E	-
Forward P/E	-
PEG	-
P/S	133.73
P/B	0.37
P/C	3.89
P/FCF	-
EV/EBITDA	-
EV/Sales	146.46
Quick Ratio	1.19
Current Ratio	1.19
Debt/Eq	0.49
LT Debt/Eq	0.47
Option/Short	No / Yes

EPS (ttm)	-16.47
EPS next Y	-1.98
EPS next Q	-0.59
EPS this Y	35.70%
EPS next Y	45.30%
EPS next 5Y	-
EPS past 3/5Y	76.80% 55.65%
Sales past 3/5Y	-42.68% -
EPS Y/Y TTM	-107.75%
Sales Y/Y TTM	-89.02%
EPS Q/Q	96.04%
Sales Q/Q	450.00%
Earnings	Nov 13 BMO
EPS/Sales Surpr.	-85.11% -31.25%

Insider Own	48.12%
Insider Trans	0.00%
Inst Own	17.96%
Inst Trans	26.36%
ROA	-28.75%
ROE	-31.88%
ROIC	-23.45%
Gross Margin	-291.07%
Oper. Margin	-23842.86%
Profit Margin	-18416.96%
SMA20	-19.33%
SMA50	-46.53%
SMA200	-71.75%
Trades

Shs Outstand	6.27M
Shs Float	4.15M
Short Float	0.31%
Short Ratio	0.43
Short Interest	0.01M
52W High	28.44 -93.53%
52W Low	1.84 0.00%
Volatility	7.82% 9.65%
ATR (14)	0.25
RSI (14)	24.76
Beta	0.88
Rel Volume	1.06
Avg Volume	29.71K
Volume	1,570

Perf Week	-14.02%
Perf Month	-30.83%
Perf Quarter	-63.49%
Perf Half Y	-77.14%
Perf YTD	-72.22%
Perf Year	-84.67%
Perf 3Y	-98.20%
Perf 5Y	-99.91%
Perf 10Y	-99.96%
Recom	1.00
Target Price	36.50
Prev Close	1.91
Price	1.84
Change %	-3.66%

Consensus

Strong Buy

Avg. Price Target

$36.50

Implied Upside

+1,883.7%

Analysts3incl. previous ratings

Rating Distribution3 Buy · 0 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Mar 30, 2021	Initiated	CCantor Fitzgerald	Overweight	$8	+334.8%
Nov 05, 2020	Initiated	AAscendiant Capital Markets	Buy	$5	+171.7%
Jun 28, 2018	Initiated	MMaxim Group	Buy	$5	+171.7%

Today 08:15AM	Lucid Diagnostics Announces Publication of Landmark 12,000-Patient Real-World EsoGuard Study (PR Newswire)
Oct-30-26 08:30AM	PAVmed to Hold Third Quarter 2026 Business Update Conference Call and Webcast on November 13, 2026 (PR Newswire)
Oct-29-26 08:30AM	Lucid Diagnostics to Hold Third Quarter 2026 Business Update Conference Call and Webcast on November 12, 2026 (PR Newswire) -5.29%
Oct-22-26 04:20PM	Lucid Diagnostics Begins Receiving Medicare Reimbursement for EsoGuard and Closes $15 Million Financing (PR Newswire) +5.85%
Sep-22-26 07:55AM	Lucid Diagnostics Advances Multiple EsoGuard and EsoCheck Payment, Billing and Coding Pathways (PR Newswire) +5.35%
07:02PM	Loading…
Aug-14-26 07:02PM	PAVmed Inc (PAVM) (Q2 2026) Earnings Call Highlights: Narrowing Losses and Strategic Progress ... (GuruFocus.com) +9.70%
08:00AM	PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results (PR Newswire)
Aug-13-26 08:00AM	Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results (PR Newswire) +12.59%
Aug-05-26 08:46AM	Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard Esophageal DNA Test (PR Newswire)
Aug-04-26 08:30AM	Lucid Diagnostics to Participate in Upcoming Investor Conferences (PR Newswire) -8.36%
Jul-31-26 08:30AM	PAVmed to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 14, 2026 (PR Newswire)
Jul-30-26 08:30AM	Lucid Diagnostics to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 13, 2026 (PR Newswire)
May-15-26 07:01PM	PAVmed Inc (PAVM) Q1 2026 Earnings Call Highlights: Strategic Restructuring and Growth ... (GuruFocus.com)
08:00AM	PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results (PR Newswire)
May-14-26 08:00AM	Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results (PR Newswire)
08:31AM	Loading…
May-01-26 08:31AM	PAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026 (PR Newswire)
Apr-30-26 08:31AM	Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026 (PR Newswire) -6.95%
Apr-24-26 10:23AM	Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock (PR Newswire)
Apr-23-26 08:30AM	Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock (PR Newswire)
Apr-09-26 08:01AM	Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference (PR Newswire)
Apr-02-26 08:01AM	PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio (PR Newswire)
Mar-30-26 07:01PM	PAVmed Inc (PAVM) Q4 2025 Earnings Call Highlights: Strategic Restructuring and Growth Initiatives (GuruFocus.com) +13.03%
08:00AM	PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results (PR Newswire)
Mar-27-26 09:21AM	What To Expect From PAVmed Inc (PAVM) Q4 2025 Earnings (GuruFocus.com)
Mar-26-26 08:00AM	Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results (PR Newswire)
Mar-16-26 09:01AM	PAVmed to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 30, 2026 (PR Newswire)
Mar-12-26 09:01AM	Lucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 26, 2026 (PR Newswire)
Feb-04-26 08:01AM	PAVmed Closes Preferred Stock and Senior Secured Note Financings, Eliminating All Previously Outstanding Convertible Securities (PR Newswire) +7.21%
Jan-22-26 09:23AM	What's Going On With PAVmed Shares Thursday? (Benzinga) -8.88%
Jan-21-26 11:22AM	Why Is PAVmed Stock Skyrocketing Wednesday? (Benzinga) +94.67%
08:00AM	Loading…
08:00AM	Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard (PR Newswire)
Dec-30-25 09:01AM	PAVmed Announces Reverse Stock Split (PR Newswire) -16.67%
Dec-09-25 08:01AM	Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection (PR Newswire) +6.17%
Nov-20-25 08:15AM	Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree (PR Newswire) -7.81%
Nov-13-25 04:02PM	PAVmed Inc (PAVM) Q3 2025 Earnings Call Highlights: Strategic Partnerships and Financial ... (GuruFocus.com) -8.49% -9.53%
08:15AM	Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (PR Newswire)
08:00AM	PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results (PR Newswire)
Nov-12-25 08:00AM	Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results (PR Newswire) +10.43%
07:39AM	PAVmed Inc (PAVM) Q3 2025 Earnings Report Preview: What to Expect (GuruFocus.com)
Oct-30-25 08:01AM	PAVmed to Hold a Business Update Conference Call and Webcast on November 13, 2025 (PR Newswire)
Oct-29-25 08:01AM	Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025 (PR Newswire)
Oct-15-25 08:01AM	Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit (PR Newswire)
Oct-10-25 12:00PM	PAVmed (PAVM) Upgraded to Strong Buy: Here's Why (Zacks)
Oct-07-25 08:01AM	PAVmed Subsidiary, Veris Health and The Ohio State University Comprehensive Cancer Center Launch Commercial Phase of Strategic Partnership Agreement (PR Newswire) +7.98%
Sep-25-25 08:01AM	Lucid Diagnostics Appoints Healthcare Industry Veteran John R. Palumbo to Board of Directors (PR Newswire)
Sep-16-25 08:01AM	Lucid Diagnostics Appoints Danielle Scelfo as Senior Vice President, Market Access & Government Affairs (PR Newswire)
Sep-11-25 09:17AM	Lucid Diagnostics Announces Closing of Public Offering of Common Stock (PR Newswire)
Sep-10-25 08:00AM	Lucid Diagnostics Announces Pricing of Public Offering of Common Stock (PR Newswire)
Sep-09-25 04:01PM	Lucid Diagnostics Announces Proposed Public Offering of Common Stock (PR Newswire)
Sep-05-25 09:16AM	Lucid Diagnostics to Host Investor Call on Monday, September 8, 2025 (PR Newswire)
Aug-28-25 06:45AM	PAVmed plans to license Dukes oesophageal imaging technology (Medical Device Network)
Aug-27-25 08:00AM	Lucid Diagnostics to Participate in the Cantor Global Healthcare Conference 2025 (PR Newswire) -7.13%
Aug-26-25 08:01AM	PAVmed Signs Letter of Intent to License Groundbreaking Endoscopic Esophageal Imaging Technology (PR Newswire) +6.16%
Aug-14-25 08:00AM	PAVmed Provides Business Update and Reports Second Quarter 2025 Financial Results (PR Newswire)
Aug-13-25 08:00AM	Lucid Diagnostics Provides Business Update and Reports Second Quarter 2025 Financial Results (PR Newswire)
Aug-05-25 08:00AM	Lucid Diagnostics to Participate in Upcoming Investor Conferences (PR Newswire) -6.86%
Jul-31-25 08:01AM	PAVmed to Hold a Business Update Conference Call and Webcast on August 14, 2025 (PR Newswire)
Jul-30-25 08:01AM	Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 13, 2025 (PR Newswire)
08:00AM	PAVmed Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule (PR Newswire)
Jul-16-25 07:31AM	MolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics' EsoGuard Esophageal DNA Test (PR Newswire)
Jun-24-25 08:01AM	PAVmed Subsidiary Veris Health Completes $2.5 Million Direct Equity Financing (PR Newswire)
Jun-18-25 12:01PM	Major California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA Test (PR Newswire)
Jun-04-25 08:41AM	PAVmed subsidiary Veris Health partners with Ohio State University cancer center (TipRanks)
Jun-03-25 08:31AM	PAVmed Subsidiary, Veris Health, Enters into Strategic Partnership Agreement with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute (PR Newswire)
May-27-25 07:31AM	Lucid Diagnostics to Join Russell 2000 and Russell 3000 Indexes (PR Newswire)
May-15-25 08:01AM	PAVmed Provides Business Update and Reports First Quarter 2025 Financial Results (PR Newswire) -13.72%
May-14-25 08:01AM	Lucid Diagnostics Provides Business Update and Reports First Quarter 2025 Financial Results (PR Newswire)
May-01-25 08:31AM	PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025 (PR Newswire) +13.17%
Apr-30-25 08:31AM	Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025 (PR Newswire)
Apr-28-25 12:00PM	PAVmed (PAVM) Upgraded to Buy: Here's What You Should Know (Zacks) -5.26%
Apr-24-25 08:01AM	NCI-Sponsored Study Shows Positive Data for Lucid Diagnostics' EsoGuard Esophageal DNA Test in Patients Without Symptomatic GERD (PR Newswire)
Apr-11-25 09:23AM	Lucid Diagnostics Announces Closing of Public Offering of Common Stock (PR Newswire)
Apr-09-25 07:24PM	Lucid Diagnostics Announces Pricing of Public Offering of Common Stock (PR Newswire) +15.21%
04:01PM	Lucid Diagnostics Announces Proposed Public Offering of Common Stock (PR Newswire)
Apr-03-25 09:00AM	Lucid Diagnostics to Participate in Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference (PR Newswire)
Mar-27-25 08:01AM	Lucid Diagnostics Launches 'Embrace the Future' Campaign Showcasing EsoCheck's Groundbreaking Collect+Protect Esophageal Cell Collection Technology (PR Newswire) -5.77%
Mar-25-25 11:08AM	PAVmed Inc. (PAVM) Q4 2024 Earnings Call Transcript (SeekingAlpha) -5.06%
08:01AM	PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results (PR Newswire)
Mar-24-25 08:01AM	Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results (PR Newswire)
Mar-20-25 08:31AM	Lucid Diagnostics Announces Updated National Comprehensive Cancer Network (NCCN) Guidelines Now Include Esophageal Precancer Screening (PR Newswire)
Mar-18-25 08:31AM	Lucid Diagnostics' ENVET-BE Clinical Utility Study of EsoGuard Esophageal Precancer Testing Accepted for Peer-Reviewed Publication (PR Newswire)
Mar-13-25 07:36AM	Lucid Diagnostics Secures First Positive Commercial Insurance Coverage Policy for its EsoGuard Esophageal DNA Test (PR Newswire)
Mar-11-25 09:01AM	PAVmed to Hold a Business Update Conference Call and Webcast on March 25, 2025 (PR Newswire)
Mar-10-25 09:01AM	Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 24, 2025 (PR Newswire)
Mar-05-25 04:45PM	Lucid Diagnostics Announces Closing of $15.3 Million Registered Direct Offering (PR Newswire)
Mar-04-25 08:25AM	Lucid Diagnostics Announces $15.3 Million Registered Direct Offering (PR Newswire)
Feb-27-25 08:31AM	Renowned Investigators Awarded $8 Million NIH Grant to Study Lucid Diagnostics' EsoGuard in At-Risk Patients without Symptomatic GERD (PR Newswire) +10.00%
Feb-25-25 08:31AM	Lucid Diagnostics Regains Compliance with Nasdaq Minimum Bid Price Requirement (PR Newswire)
Feb-24-25 08:31AM	PAVmed and Subsidiary Veris Health Complete Private Placement Financing (PR Newswire)
Feb-20-25 08:31AM	Lucid Diagnostics Executes First Concierge Medicine Contract with LEAA Health (PR Newswire)
Feb-18-25 08:30AM	PAVmed Regains Compliance with Nasdaq Stockholders' Equity Requirement (PR Newswire) +6.08%
Feb-06-25 08:57AM	Lucid Diagnostics to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (PR Newswire)
Jan-13-25 07:56AM	Lucid Diagnostics Announces Record Quarterly EsoGuard Test Volume (PR Newswire)
Dec-23-24 08:01AM	Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule (PR Newswire) +10.82%
Dec-19-24 08:01AM	Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for Firefighters (PR Newswire)
Dec-11-24 08:01AM	Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard Esophageal DNA Test Accepted for Peer-Reviewed Publication (PR Newswire)
Dec-03-24 08:01AM	Lucid Diagnostics Completes Convertible Debt Refinancing to Strengthen Balance Sheet and Extend Cash Runway Past Key Near-Term Milestones (PR Newswire) +6.31%
Nov-20-24 07:56AM	Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard Esophageal DNA Test (PR Newswire)
Nov-18-24 08:15AM	Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (PR Newswire) -10.53%
Nov-14-24 08:01AM	PAVmed Provides Business Update and Third Quarter 2024 Financial Results (PR Newswire) +6.86%

Show Previous News

PAVmed, Inc. is a multi-product life sciences company, which engages in the innovation, development, acquisition, and commercialization of products that target unmet medical needs with large addressable market opportunities. Its products include Lucid Diagnostics and Veris Health. The company was founded by Lishan Aklog and Brian J. deGuzman on June 26, 2014 and is headquartered in New York, NY.

Chairman & CEODr. Lishan Aklog M.D.

President & CFOMr. Dennis M. McGrath CPA

Executive VP & COOMr. Shaun M. O'Neill M.B.A.

Executive VPMr. Michael Adam Gordon

Executive VPDr. Brian J. deGuzman M.D.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PAVM

PAVmed Inc

Upgrade your Finviz experience